Evaluation of the Dual-Chamber Pen Design for the Injection of Exenatide Once Weekly for the Treatment of Type 2 Diabetes

Por LaRue, Susan, Malloy, Jaret
Publicado no J Diabetes Sci Technol (2015)

In vivo clearance of surfactant lipids during acute pulmonary inflammation.

Por Malloy, Jaret L, Wright, Jo Rae
Publicado em 2004

Increased variability and abnormalities in pancreatic enzyme concentrations in otherwise asymptomatic subjects with type 2 diabetes

Por Malloy, Jaret, Gurney, Kate, Shan, Kevin, Yan, Ping, Chen, Steve
Publicado em 2012

Safety and tolerability of exenatide once weekly in patients with type 2 diabetes: an integrated analysis of 4,328 patients

Por MacConell, Leigh, Gurney, Kate, Malloy, Jaret, Zhou, Ming, Kolterman, Orville
Publicado no Diabetes Metab Syndr Obes (2015)

Assessment of Pancreatic β-Cell Function: Review of Methods and Clinical Applications

Por Cersosimo, Eugenio, Solis-Herrera, Carolina, Trautmann, Michael E., Malloy, Jaret, Triplitt, Curtis L.
Publicado em 2014

Weight-Related Quality of Life, Health Utility, Psychological Well-Being, and Satisfaction With Exenatide Once Weekly Compared With Sitagliptin or Pioglitazone After 26 Weeks of Tr...

Por Best, Jennie H., Rubin, Richard R., Peyrot, Mark, Li, Yan, Yan, Ping, Malloy, Jaret, Garrison, Louis P.
Publicado em 2011

Exenatide at therapeutic and supratherapeutic concentrations does not prolong the QT(c) interval in healthy subjects

Por Darpö, Börje, Sager, Philip, MacConell, Leigh, Cirincione, Brenda, Mitchell, Malcolm, Han, Jenny, Huang, Wenying, Malloy, Jaret, Schulteis, Christine, Shen, Larry, Porter, Lisa
Publicado em 2013

Impaired Pulmonary Defense Against Pseudomonas aeruginosa in VEGF Gene Inactivated Mouse Lung

Por Breen, Ellen C., Malloy, Jaret L., Tang, Kechun, Xia, Feng, Fu, Zhenxing, Hancock, Robert E. W., Overhage, Joerg, Wagner, Peter D., Spragg, Roger G.
Publicado em 2013

One-Year Treatment With Exenatide Improves β-Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic Patients: A randomized, controlled trial

Por Bunck, Mathijs C., Diamant, Michaela, Cornér, Anja, Eliasson, Bjorn, Malloy, Jaret L., Shaginian, Rimma M., Deng, Wei, Kendall, David M., Taskinen, Marja-Riitta, Smith, Ulf, Yki-Järvinen, Hannele, Heine, Robert J.
Publicado em 2009

Effects of MetAP2 inhibition on hyperphagia and body weight in Prader-Willi syndrome: a randomized, double-blind, placebo-controlled trial

Por McCandless, Shawn E., Yanovski, Jack A., Miller, Jennifer, Fu, Cary, Bird, Lynne M., Salehi, Parisa, Chan, Christine L., Stafford, Diane, Abuzzahab, M. Jennifer, Viskochil, David, Barlow, Sarah E., Angulo, Moris, Myers, Susan E., Whitman, Barbara Y., Styne, Dennis, Roof, Elizabeth, Dykens, Elisabeth M., Scheimann, Ann O., Malloy, Jaret, Zhuang, Dongliang, Taylor, Kristin, Hughes, Thomas E., Kim, Dennis D., Butler, Merlin G.
Publicado no Diabetes Obes Metab (2017)